Join experts Krish Patel, MD, specializing in mantle cell lymphoma treatment, Marek Trněný, MD, PhD, a key contributor to BTK inhibitor trials, and Michael Wang, MD, who offers insights on therapeutic sequencing. They delve into groundbreaking trials like ECHO and SHINE, discussing the role of BTK inhibitors and their effectiveness for older patients. Notably, they address optimal sequencing methods to prevent cross-resistance and strategies for managing cardiac toxicities. Their collaboration underscores a comprehensive approach to enhancing patient care.

In this podcast, experts Stephen Ansell and Marek Trněný discuss the evolving treatment landscape in mantle cell lymphoma. They explore the impact of stem cell transplants, the emergence of novel therapies, and the importance of maintenance therapy. Different treatment approaches, including CAR T cell therapy, are also discussed along with the potential for cure and long-term survival rates.